Vident Advisory’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3M Sell
558,156
-484,525
-46% -$11.4M 0.1% 185
2026
Q1
$15.6M Buy
1,042,681
+83,117
+9% +$1.42M 0.13% 136
2025
Q4
$14M Buy
959,564
+81,875
+9% +$1.43M 0.13% 144
2025
Q3
$15.7M Sell
877,689
-935,325
-52% -$13.7M 0.15% 131
2025
Q2
$30.9M Sell
1,813,014
-632,308
-26% -$6.33M 0.35% 60
2025
Q1
$17.7M Buy
2,445,322
+253,097
+12% +$2.88M 0.26% 84
2024
Q4
$30.8M Buy
2,192,225
+546,270
+33% +$8.07M 0.54% 37
2024
Q3
$19.5M Buy
1,645,955
+47,457
+3% +$492K 0.49% 40
2024
Q2
$14.9M Buy
1,598,498
+455,401
+40% +$2.33M 0.41% 52
2024
Q1
$4.05M Buy
+1,143,097
New +$3.96M 0.08% 245

Other funds holding CORZ

Vident Advisory's CORZ Position: Q2 2026 in Review

Vident Advisory reduced its Core Scientific (CORZ) stake by 46% in Q2 2026, selling an estimated $11.4M and leaving 558,156 shares worth $14.3M. The position accounts for 0.1% of the portfolio, ranked #185.

Vident Advisory first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $30.9M in Q2 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Vident Advisory held 558,156 shares of Core Scientific worth $14.3M as of Q2 2026.
  • Vident Advisory sold 484,525 Core Scientific shares in Q2 2026, an estimated $11.4M.
  • Core Scientific made up 0.1% of Vident Advisory's portfolio in Q2 2026, its #185 holding.
  • Vident Advisory first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • Vident Advisory's Core Scientific position peaked at $30.9M in Q2 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.